» Articles » PMID: 17493689

The Involvement of Mitochondria in the Pathogenesis of Multiple Sclerosis

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2007 May 12
PMID 17493689
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis is an immune-mediated disorder of the central nervous system. Major pathological characteristics include the loss of oligodendrocytes, demyelination and neuroaxonal depletion in association with inflammation. The complex pathophysiology of tissue loss is only partially understood. Here we discuss a variety of mitochondrion-driven mechanisms involved in immune regulation, oligodendrocyte depletion and neurodegeneration. The recognition of a mitochondrial link between inflammation and neurodegeneration underscores the importance of an early aggressive intervention for halting inflammation and preventing neurodegeneration, and identifies the mitochondrion as a potential target in neuroprotection.

Citing Articles

Characterization of hyperpolarization-activated cyclic nucleotide-gated channels in oligodendrocytes.

Lyman K, Han Y, Robinson A, Weinberg S, Fisher D, Heuermann R Front Cell Neurosci. 2024; 18:1321682.

PMID: 38469353 PMC: 10925711. DOI: 10.3389/fncel.2024.1321682.


Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article.

Bagheri S, Haddadi R, Saki S, Kourosh-Arami M, Rashno M, Mojaver A Front Neurosci. 2023; 17:1188839.

PMID: 37424991 PMC: 10326389. DOI: 10.3389/fnins.2023.1188839.


The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis.

Polyak H, Galla Z, Nanasi N, Cseh E, Rajda C, Veres G Biomedicines. 2023; 11(3).

PMID: 36979924 PMC: 10046567. DOI: 10.3390/biomedicines11030945.


Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma.

Polyak H, Cseh E, Bohar Z, Rajda C, Zadori D, Klivenyi P Heliyon. 2021; 7(2):e06124.

PMID: 33553777 PMC: 7856478. DOI: 10.1016/j.heliyon.2021.e06124.


Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia.

Gouvea-Junqueira D, Falvella A, Antunes A, Seabra G, Brandao-Teles C, Martins-de-Souza D Front Psychiatry. 2020; 11:379.

PMID: 32425837 PMC: 7203658. DOI: 10.3389/fpsyt.2020.00379.